Shopping Cart
Remove All
  • TargetMol
    Your shopping cart is currently empty

3-Indolepropionic acid

Copy Product Info
😃Good
Catalog No. T5297Cas No. 830-96-6
Alias IPA, Indolepropionic acid, indole-3-propionic acid

3-Indolepropionic acid (Indolepropionic acid) is shown to be a powerful antioxidant with potential in the treatment for Alzheimer's disease.

3-Indolepropionic acid

3-Indolepropionic acid

Copy Product Info
😃Good
Purity: 99.94%
Catalog No. T5297Alias IPA, Indolepropionic acid, indole-3-propionic acidCas No. 830-96-6
3-Indolepropionic acid (Indolepropionic acid) is shown to be a powerful antioxidant with potential in the treatment for Alzheimer's disease.
Pack SizePriceUSA WarehouseGlobal WarehouseQuantity
5 g$29-In Stock
1 mL x 10 mM (in DMSO)$29In StockIn Stock
Add to Cart
Add to Quotation
In Stock Estimated shipping dateUSA Warehouse[1-2 days] Global Warehouse[5-7 days]
All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose.
Questions
TargetMol
View More

Batch Information

Select Batch
Purity:99.94%
Appearance:Solid
Color:White to Yellow
Contact us for more batch information

Resource Download

Product Introduction

3-Indolepropionic acid AI Summary
3-Indolepropionic acid exhibits a variety of biological activities and properties. It has notable antioxidant properties, demonstrating hydroxyl radical scavenging activity at 1 µmol/mL with an activity of 95.7 nM and radical reducing potency with an activity of 96.5 nM. The compound inhibits hydrogen peroxide, peroxynitrite, and doxorubicin-induced cell death in mixed cortical cells of E15 Sprague-Dawley rat embryos at 10 µM, with respective inhibitions of 87.7%, 83.8%, and 76.1%. Additionally, it protects rotifers from hydrogen peroxide and doxorubicin toxicity at the same concentration, with activities of 67.9% and 53.8%. 3-Indolepropionic acid has a high permeability coefficient indicated by a LogP app value of -5.68 and a partition coefficient with a LogP value of 1.75. It inhibits human recombinant KAT1 with an IC50 of 140,000 nM and shows antagonist activity at the human T1R2/T1R3 receptor, with an IC50 value > 1,000,000 nM for sucralose-induced calcium mobilization inhibition. In terms of antiviral properties, 3-Indolepropionic acid inhibits SARS-CoV-2-induced cytotoxicity in both Caco-2 and VERO-6 cells at a concentration of 10 µM, though with variable efficacy (-17.48% and -0.15% inhibition, respectively). It also inhibits the SARS-CoV-2 3CL-Pro protease by 10.15% at 20 µM. Moreover, 3-Indolepropionic acid exhibits antitubercular activity with a MIC50 of 68,000 nM against Mycobacterium tuberculosis and shows oral bioavailability of 30% in CD-1 mice at 100 mg/kg. It reduces bacterial load in infected mouse spleen with a fold change of 7.0 at the same dosage administered orally 6 days per week for 4 weeks. The compound also shows modest inhibition (6.28% and -8.28%) in an enzymatic assay of human HDAC6 using peptide substrates. In summary, 3-Indolepropionic acid displays multifaceted bioactivity, including antioxidant, antiviral, and antitubercular properties, alongside notable permeability and solubility characteristics..
Note: Summary generated by AI. Data source: ChEMBL
Bioactivity
Description
3-Indolepropionic acid (Indolepropionic acid) is shown to be a powerful antioxidant with potential in the treatment for Alzheimer's disease.
SynonymsIPA, Indolepropionic acid, indole-3-propionic acid
Chemical Properties
Molecular Weight189.21
FormulaC11H11NO2
Cas No.830-96-6
SmilesO=C(O)CCC1=CNC=2C=CC=CC21
Relative Density.0.960 g/mL at 20°C
Storage & Solubility Information
StoragePowder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature.
Solubility Information
DMSO: 100 mg/mL (528.51 mM), Sonication is recommended.
H2O: < 1 mg/mL (insoluble)
Ethanol: 50 mg/mL (264.26 mM), Sonication is recommended.
In Vivo Formulation
10% DMSO+40% PEG300+5% Tween 80+45% Saline: 4 mg/mL (21.14 mM), Sonication is recommended.
Please add the solvents sequentially, clarifying the solution as much as possible before adding the next one. Dissolve by heating and/or sonication if necessary. Working solution is recommended to be prepared and used immediately. The formulation provided above is for reference purposes only. In vivo formulations may vary and should be modified based on specific experimental conditions.
Solution Preparation Table
Ethanol/DMSO
1mg5mg10mg50mg
1 mM5.2851 mL26.4257 mL52.8513 mL264.2566 mL
5 mM1.0570 mL5.2851 mL10.5703 mL52.8513 mL
10 mM0.5285 mL2.6426 mL5.2851 mL26.4257 mL
20 mM0.2643 mL1.3213 mL2.6426 mL13.2128 mL
50 mM0.1057 mL0.5285 mL1.0570 mL5.2851 mL
100 mM0.0529 mL0.2643 mL0.5285 mL2.6426 mL

Calculator

  • Molarity Calculator
  • Dilution Calculator
  • Reconstitution Calculator
  • Molecular Weight Calculator

In Vivo Formulation Calculator (Clear solution)

Please enter your animal experiment information in the following box and click Calculate to obtain the stock solution preparation method and in vivo formula preparation method:
TargetMol | Animal experiments For example, if the intended dosage is 10 mg/kg for animals weighing 20 g , with a dosing volume of 100 μL per animal, TargetMol | Animal experiments and a total of 10 animals are to be administered, using a formulation of TargetMol | reagent 10% DMSO+ 40% PEG300+ 5% Tween 80+ 45% Saline/PBS/ddH2O , the resulting working solution concentration would be 2 mg/mL.
Stock Solution Preparation:

Dissolve 2 mg of the compound in 100 μL DMSOTargetMol | reagent to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.

Preparation of the In Vivo Formulation:

1) Add 100 μL of the DMSOTargetMol | reagent stock solution to 400 μL PEG300TargetMol | reagent and mix thoroughly until the solution becomes clear.

2) Add 50 μL Tween 80 and mix well until fully clarified.

3) Add 450 μL Saline,PBS or ddH2OTargetMol | reagent and mix thoroughly until a homogeneous solution is obtained.

This example is provided solely to demonstrate the use of the In Vivo Formulation Calculator and does not constitute a recommended formulation for any specific compound. Please select an appropriate dissolution and formulation strategy based on your experimental model and route of administration.
All co-solvents required for this protocol, includingDMSO, PEG300/PEG400, Tween 80, SBE-β-CD, and Corn oil, are available for purchase on the TargetMol website.
1 Enter information below:
mg/kg
g
μL
2 Enter the in vivo formulation:
% DMSO
%
% Tween 80
% Saline/PBS/ddH2O

Dose Conversion

You can also refer to dose conversion for different animals. More Dose Conversion

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc

Keywords

Related Tags: buy 3-Indolepropionic acid | purchase 3-Indolepropionic acid | 3-Indolepropionic acid cost | order 3-Indolepropionic acid | 3-Indolepropionic acid chemical structure | 3-Indolepropionic acid formula | 3-Indolepropionic acid molecular weight